ProCE Banner Activity

Overcoming Missed Opportunities for Hepatitis Delta Screening and Surveillance

Clinical Thought
My thinking about HDV testing recommendations has shifted in recent years. Here’s why.

Released: May 18, 2022

Expiration: May 17, 2023

No longer available for credit.

Share

Faculty

Norah Terrault

Norah Terrault, MD, MPH

Assistant Professor, Medicine and Surgery
Director of Viral Hepatitis Research, Liver Transplantation Program
University of California, San Francisco
San Francisco, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Norah Terrault, MD, MPH

Assistant Professor, Medicine and Surgery
Director of Viral Hepatitis Research, Liver Transplantation Program
University of California, San Francisco
San Francisco, California

Norah Terrault, MD, MPH, has disclosed that she has received funds for institutional grant support from Gilead Sciences, GlaxoSmithKline, and Roche/Genentech and consulting fees from Entourage Pharma, ENYO, EXIGO, and Moderna.